Skip to main content
Clinical Trials/NCT05973019
NCT05973019
Recruiting
Not Applicable

Repetitive Transcranial Magnetic Stimulation Improves Functional Performance in Spinocerebellar Ataxia

Changhua Christian Hospital1 site in 1 country10 target enrollmentSeptember 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Transcranial Magnetic Stimulation
Sponsor
Changhua Christian Hospital
Enrollment
10
Locations
1
Primary Endpoint
Changes of Timed up and go
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Spinocerebellar ataxia (SCA) is a group of inherited brain disorders. SCA often result in poor limb coordination. This study aims to discover the effects of repeated transcranial magnetic stimulation (rTMS) on balance & gait in SCA. The hypothesis of this study is that rTMS might improve SCA limb functional performance.

Detailed Description

rTMS has been shown that improves walking speed and balance performance, however, the optimal treatment protocols have not been approved. Past studies used different frequencies 1 Hz, 5 Hz and 10 Hz to improve functional performance. The results might be affected by the types of SCA. In this study, we will focus on the SCA type 3 to assess the effects on high frequency (10 Hz) of rTMS intervention.

Registry
clinicaltrials.gov
Start Date
September 1, 2023
End Date
August 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sen-yung Liu

Chief Medical Officer

Changhua Christian Hospital

Eligibility Criteria

Inclusion Criteria

  • SCA type 3
  • independently walk with/without an assistive device
  • SARA greater than 3

Exclusion Criteria

  • Epilepsy history
  • Unstable blood pressure
  • Brain Trauma
  • Alcoholism, drug abuse, antipsychotics drug use
  • Metallic hardware (e.g. - cochlear implants, brain stimulators or electrodes, aneurysm clips) anywhere in head.
  • Dementia, depression

Outcomes

Primary Outcomes

Changes of Timed up and go

Time Frame: Baseline (T0), 6 days after first rTMS intervention (T1), 12 days after first rTMS intervention (T2),

Timed up and go (TUG): Patients wear their regular footwear and can use a walking aid, if needed. Begin by having the patient sit back in a standard arm chair and identify a line 3 meters, or 10 feet away, on the floor.

Changes of SARA

Time Frame: Baseline (T0), 6 days after first rTMS intervention (T1), 12 days after first rTMS intervention (T2),

Scale for the Assessment and Rating of Ataxia (SARA): a tool for assessing ataxia. It has eight categories with accumulative score ranging from 0 (no ataxia) to 40 (most severe ataxia).

Changes of International Cooperative Ataxia Rating Scale

Time Frame: Baseline (T0), 6 days after first rTMS intervention (T1), 12 days after first rTMS intervention (T2),

International Cooperative Ataxia Rating Scale (ICARS): quantify the level of impairment as a result of ataxia as related to hereditary ataxias. Disorders rated as subscales within the ICARS are: Postural and gait disturbances, Limb Ataxia, Dysarthria, and Oculomotor disorders.It translates the symptomatology of cerebellar ataxia into a scoring system out of 100.

Changes of Center of pressure trajectory

Time Frame: Baseline (T0), 6 days after first rTMS intervention (T1), 12 days after first rTMS intervention (T2),

Center of pressure (COP): he trajectory of the COP, commonly known as a stabilogram, during static balance is frequently used to measure postural control. When standing still on a force platform, the COP is thought to be an indicator of the motor mechanisms involved in maintaining balance with opened-eyes or closed-eyes. Two trials for each condition were performed within 5 minutes.

Changes of Electromyography of Gait

Time Frame: Baseline (T0), 6 days after first rTMS intervention (T1), 12 days after first rTMS intervention (T2),

A wireless surface Electromyography (EMG) is used to collect lower extremities muscle activation signals during walking in a walkway.

Changes of Berg Balance Scale

Time Frame: Baseline (T0), 6 days after first rTMS intervention (T1), 12 days after first rTMS intervention (T2),

Berg Balance Scale (BBS): a widely used assessment to determine a person's balance abilities. The test contains 14 simple tasks, scoring ranges from 0 to 56. The lower your score, the more at risk you are for losing your balance. The entire process takes about 20 minutes to complete.

Changes of Kinematic of Gait

Time Frame: Baseline (T0), 6 days after first rTMS intervention (T1), 12 days after first rTMS intervention (T2),

The joint angles of hip, knee, ankle are collected during walking in a 10 meters walkway.

Secondary Outcomes

  • Changes of Mini-mental state examination(Baseline (T0))
  • Concentration of Neurofilament(Baseline (T0), 12 days after first rTMS intervention (T2))

Study Sites (1)

Loading locations...

Similar Trials